Abstract
Aim: Recently, several clinical trials have tested the effect of prenatal vitamin D supplementation in gestational diabetes mellitus (GDM) patients and their newborns. However, their participant attrition, an important determinant of the internal validity, remains poorly explored. Therefore, this review protocol is proposed, which aims to compare it between prenatal vitamin D supplemented and not supplemented GDM patients. Method: Randomized clinical trials studying the above will be searched mainly in different electronic databases. It will search for the English language articles irrespective of publication date. Data concerning the reviewed trials design, population, interventions, and outcome of interest will be extracted. Subsequently, their risk of bias will be assessed. Outcome data between the interventions will be juxtaposed meta-analytically to estimate the risk ratio. Next, the statistical heterogeneity (by Chi2 and I2 statistics) and publication bias (using funnel plot and Eggers test) among the trials will be evaluated. Subgroup analysis will follow if the heterogeneity is high. Finally, a sensitivity analysis will iterate the meta-analysis using an alternative model and by eliminating a trial every time. Statistical significance will be determined at p<0.05 and 95% CI. All analyses will be done in Stata. If a meta-analysis is not possible, a narrative reporting will ensue. Results: The review will follow the PRISMA reporting guideline. Any statistically significant findings evidence quality will be graded by the GRADE approach. Conclusion: The proposed review will compare the risk of loss to follow up among GDM patients complemented and not complemented with prenatal vitamin D.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was not required since do not directly involve human subjects
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
not applicable
